Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Medicine (Baltimore) ; 103(2): e36855, 2024 Jan 12.
Article in English | MEDLINE | ID: mdl-38215085

ABSTRACT

INTRODUCTION: Inadvertent perioperative hypothermia (IPH), defined as core body temperature below 36°C, is associated with various complications. Shoulder arthroscopy is a risk factor of IPH. This study aimed to compare the incidence of IPH between general anesthesia (GA) and interscalene brachial plexus block (ISBPB) for shoulder arthroscopy. METHOD: Patients scheduled for shoulder arthroscopy were prospectively enrolled and randomly assigned to GA or ISBPB groups. The body temperature of the patients was measured from baseline to the end of anesthesia and in the post-anesthetic care unit to compare the incidence of IPH. RESULTS: Of the 114 patients initially identified, 80 were included in the study (GA = 40, ISBPB = 40). The incidence of IPH differed significantly between the groups, with GA at 52.5% and ISBPB at 30.0% (P = .04). Profound IPH (defined as < 35.0°C) occurred in 2 patients with GA. Upon arrival at the post-anesthesia care unit, the GA group exhibited a significantly lower mean body temperature (35.9 ±â€…0.6°C) than the ISBPB group (36.1 ±â€…0.2°C, P = .04). CONCLUSION: The incidence of IPH in the GA group was higher than that in the ISBPB group during shoulder arthroscopy, suggesting that ISBPB may be a preferable anesthetic technique for reducing risk of IPH in such procedures.


Subject(s)
Anesthetics , Brachial Plexus Block , Hypothermia , Humans , Brachial Plexus Block/adverse effects , Brachial Plexus Block/methods , Shoulder/surgery , Prospective Studies , Hypothermia/epidemiology , Hypothermia/etiology , Hypothermia/prevention & control , Arthroscopy/adverse effects , Arthroscopy/methods , Incidence , Anesthesia, General/adverse effects , Anesthesia, General/methods , Pain, Postoperative
2.
Medicine (Baltimore) ; 102(47): e36126, 2023 Nov 24.
Article in English | MEDLINE | ID: mdl-38013296

ABSTRACT

RATIONALE: Angiotensin II receptor blockers (ARBs) are currently considered first-line antihypertensive drugs, effectively inhibiting the renin-angiotensin-aldosterone system. However, ARBs have been associated with intraoperative hypotension during general anesthesia. Although it is recommended to discontinue ARBs for 24 hours before surgery, the optimal duration of discontinuation remains unclear. We present a severe refractory hypotension encountered during general anesthesia despite discontinuing ARBs for 48 hours before anesthesia. PATIENT CONCERNS: A severe refractory hypotension occurred during the induction of general anesthesia for cranioplasty in a 66-year-old male patient (170 cm/75 kg). The patient was taking azilsartan, angiotensin receptor blocker, for hypertension, which was discontinued 48 hours before anesthesia induction. Despite repeated administration of ephedrine and continuous infusion of norepinephrine, hemodynamic instability did not improve. Therefore, the surgery was postponed. DIAGNOSIS: The patient was diagnosed with angiotensin receptor blocker-induced refractory hypotension. INTERVENTIONS: Before the second surgery, the angiotensin receptor blocker was discontinued 96 hours prior to the surgery. Invasive blood pressure monitoring was performed before anesthesia induction, and vasopressin was prepared. General anesthesia was induced using remimazolam and maintained with desflurane. OUTCOMES: The surgery was completed successfully without occurrence of refractory hypotension. LESSONS: Refractory hypotension induced by Angiotensin receptor blockers can still occur even after discontinuing the medication for 48 hours before induction of general anesthesia. Despite withholding the medication, caution should be practiced regarding hypotension during general anesthesia in patient taking ARBs.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors , Hypotension , Male , Humans , Aged , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Angiotensin Receptor Antagonists/therapeutic use , Hypotension/etiology , Anesthesia, General/adverse effects
3.
Medicine (Baltimore) ; 102(42): e35497, 2023 Oct 20.
Article in English | MEDLINE | ID: mdl-37861519

ABSTRACT

RATIONALE: Remimazolam, a novel benzodiazepine, is known to have less respiratory depression compared to other anesthetic agents, and it also has a reversal agent that can be used in emergency situations. Remimazolam with these characteristics can be usefully utilized in the anesthetic management of patients with difficult airway. PATIENT CONCERNS: A 78-year-old female patient was scheduled proximal humerus fracture surgery. The patient occasionally complained dyspnea and had multiple comorbidities including thyroid goiter, dementia, and delirium. DIAGNOSES: The patient had a large thyroid goiter compressing and deviating the trachea. A short neck with increased circumference was confirmed. A difficult airway was anticipated in the preanesthetic evaluation. INTERVENTIONS: Sedation with remimazolam followed by regional anesthesia was performed for the surgery. OUTCOMES: The surgery was completed without complications. The patient recovered and was discharged on 15th postoperative days. LESSONS: The use of remimazolam for sedation may be an appropriate option in the anesthetic management of patients with difficult airway.


Subject(s)
Anesthesia, Conduction , Anesthetics , Goiter , Female , Humans , Aged , Benzodiazepines
SELECTION OF CITATIONS
SEARCH DETAIL
...